Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 6—June 2014
Letter

Hepatitis E Virus Infection, Papua New Guinea, Fiji, and Kiribati, 2003–2005

John S. Halliday1Comments to Author , G.L. Abby Harrison1, Anthony Brown, Jeremy G. Hunter, Richard Bendall, David Penny, Tebuka Toatu, Mohammad Y. Abdad, Paul Klenerman, Eleanor Barnes, and Harry R. Dalton
Author affiliations: University of Oxford, Oxford, UK (J.S. Halliday, A. Brown, P. Klenerman, E. Barnes); Royal Melbourne Hospital, Melbourne, Victoria, Australia (J.S. Halliday); Walter and Eliza Hall Institute of Medical Research, Melbourne (G.L.A. Harrison); University of Exeter, Truro, UK (J.G. Hunter, R. Bendall, H.R. Dalton); Massey University, Palmerston North, New Zealand (D. Penny); Disease Surveillance, Control and Research Unit, Secretariat of the Pacific, Suva, Republic of the Fiji (T. Toatu); Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea (M.Y. Abdad)

Main Article

Table

Seroprevalence of HEV, Papua New Guinea, Fiji, and Kiribati, 2003–2005*

Age group, y Papua New Guinea†
 Fiji†
 Kiribati†
All HEV IgG+, % (95% CI) All HEV IgG+, % (95% CI) All HEV IgG+, % (95% CI)
Children 12/105‡ 11.4 (6.6–18.9) 3/91‡ 3.3 (1.1–9.2) 12/90 13.3 (7.8–21.2)
<1 0/21 0 1/23 4.3 1/8 12.5
1–<2 3/26 11.5 1/19 5.3 2/18 11.1
2–<5 6/24 25 1/35‡ 2.9 6/48 12.5
5–<10 1/23‡ 4.3 0/10‡ 0 0/10 0
10–<16 1/6 16.7 0/3‡ 0 0/2 0
Unknown
 1/5
 20
0/1
 0
3/4
 75
Adults 71/440 16.1 (14.2–21.3) 3/174 1.7 (0.6–4.9) 9/148 6.0 (3.2–11.1)
16–19 7/24 29.2 0/8 0 0/2 0
20–29 19/162 11.7 2/76 2.6 2/61 3.3
30–39 18/143 12.6 0/41 0 3/53 3.7
40–49 13/70 18.6 1/28 3.6 2/19 5.3
50–59 5/22 22.7 0/14 0 2/9 22.2
60–69 3/7 42.9 0/5 0 0/2 0
70–79 0/4 0 0/0 0 0/2 0
Unknown
 0/9
 0
0/1
 0
0/0
 0
Total 83/545‡ 15.2 (12.5–18.5) 6/265‡ 2.3 (1.0–4.9) 21/238 8.8 (5.8–13.1)

*An expanded version of this table that includes sex data is available online (wwwnc.cdc.gov/EID/article/20/7/13-0562-T1.htm). HEV, hepatitis E virus; +, positive.
†No. HEV IgG–positive persons/total no. persons in each group.
‡In these groups.

Main Article

1These authors contributed equally to this article.

Page created: May 19, 2014
Page updated: May 19, 2014
Page reviewed: May 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external